WESTBOROUGH, Mass., May 24 /PRNewswire/ -- IBC's Lead Discovery and Lead Optimization Conference will address the challenges in the lead identification, hit to lead and lead optimization stages of drug discovery. This conference will take place in Boston, Massachusetts on August 7-10, 2006 as part of the 11th Annual Drug Discovery Technology(R) & Development World Congress.
This year's conference features a 300% increase in content/speakers dedicated to lead discovery and optimization/chemistry approaches ... 33 sessions this year versus 10 sessions in 2005. In addition, this conference will feature 14 lead optimization case studies representing several large, mid-size and smaller companies who will discuss their challenges, different approaches and successes at the lead optimization and compound selection phases of drug discovery.
On Thursday, August 10, 2006, the Lead Discovery and Lead Optimization conference will include featured presenter -- Christopher, P. Austin Director of the NIH Chemical Genomics Center present on the NIH Molecular Libraries Initiative Roadmap. This presentation will discuss how the NIH Molecular Libraries initiative is helping to facilitate the translation of genomic discoveries into therapeutics by encouraging follow-up investigation and chemical optimization of chemical probes produced through the initiative. It will also expand on the purpose of the initiative which is to encourage the public and private sectors to join forces for the purposes of basic biomedical research and drug development.
Additional session topics at this conference include: exploring chemistry space, filling the gaps in compound libraries and enhancing compound collections, fragment based approaches, technology applications and novel chemistry techniques and strategic perspectives in drug discovery.
The Drug Discovery Technology(R) & Development World Congress expects more than 4,000 pharmaceutical, biotechnology, government and academic researchers, executives and technology providers to participate. This year's program has expanded and includes six dedicated conferences:
* Targeting Disease and Evaluating Disease-Relevant Targets * Lead Discovery and Lead Optimization * Discovery to Development: Case Studies, Safety, PK/PD and Pharmacogenomics * Biomarkers: Utility, Validation and Applications from Discovery to Clinic * R&D Strategies and Business Alliances * The Interface between Drug Discovery and Informatics
The World Congress also includes four keynote presentations from: Andrew C. von Eschenbach, M.D., Acting Commissioner, FDA and Director, National Cancer Institute, Steven M. Paul, M.D., Executive Vice President, Science and Technology, President, Lilly Research Laboratories, Eli Lilly and Company, Peter B. Corr, Ph.D., Senior Vice President, Science & Technology, Pfizer Inc and Susan Hockfield, Ph.D., President, Massachusetts Institute of Technology.
Complete details on this event can be found at http://www.drugdisc.com/us or to receive a press pass or arrange an interview with a speaker, email Dawn Eagan at deagan@ibcusa.com.
About Drug Discovery Technology(R) & Development World Congress
Drug Discovery Technology(R) & Development World Congress (DDT), now in its 11th year, is the industry's premier, international conference and exhibition to provide education on the most vital topics in drug discovery and development to help accelerate products to market. The event provides a meeting place for attendees from around the world to network, find business and scientific partners and to discuss scientific advances, R&D strategies, business alliances and informatics solutions in drug discovery and development.
About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit: http://www.IBCLifeSciences.com.
Contact: Dawn Eagan IBC Life Sciences 508-614-1679 deagan@ibcusa.com
IBC Life SciencesCONTACT: Dawn Eagan of IBC Life Sciences, +1-508-614-1679,deagan@ibcusa.com
